Glycophosphopeptical AM3 A Potential Adjuvant in the Treatment of SARS-CoV-2
NCT04987554
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class
Conditions
SARS-CoV-2 Infection
Interventions
DIETARY_SUPPLEMENT:
glycophosphopeptical AM3
OTHER:
Placebo
Sponsor
University of Valladolid
Collaborators
[object Object]
[object Object]